ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2020

The new type 2 diabetes mellitus therapy: comparison between the two classes of drugs GLPR (glucagon-like peptide receptor) agonists and SGLT2 (sodium-glucose cotransporter 2) inhibitors.

Claudio Borghi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.